Publications by authors named "Vilashini Saravanan"
Article Synopsis
- Colorectal cancer (CRC) begins with asymptomatic polyps and is the fourth leading cause of cancer-related deaths globally, presenting challenges in patient mortality and morbidity despite treatment advancements.
- Advances in nanocarrier-based drug delivery systems, such as liposomes and nanoparticles, show potential for improved diagnosis and treatment of CRC by enabling targeted delivery and theranostic applications.
- The review highlights the progress in nanocarrier technologies, including surface-engineering for targeted delivery, while also addressing the challenges and limitations in translating these innovations into clinical practice.
The challenges and difficulties associated with conventional drug delivery systems have led to the emergence of novel, advanced targeted drug delivery systems. Therapeutic drug delivery of proteins and peptides to the lungs is complicated owing to the large size and polar characteristics of the latter. Nevertheless, the pulmonary route has attracted great interest today among formulation scientists, as it has evolved into one of the important targeted drug delivery platforms for the delivery of peptides, and related compounds effectively to the lungs, primarily for the management and treatment of chronic lung diseases.
View Article and Find Full Text PDF